28th Congress of the European Association for Cancer Research (EACR 2024) covers topics such as:
- Cancer Genomics, Epigenetics and Genomic Instability
- Functional Genomics
- Genomic Alterations in Cancer
- Genetic instability
- Epigenetic mechanisms and RNA
- Deep sequencing
- Cell and Tumour Biology
- Cell Death / Autophagy
- Cell Proliferation/cell cycle
- Tumour Progression: Invasion and Metastasis
- Oncogenes and Tumour Suppressor Genes
- Tumour Microenvironment
- Metastases and EMT
- Tumour Immunology AND Inflammation
- Tumour Angiogenesis
- Senescence
- Aging and Cancer
- Cancer Initiating Cells / Cancer Stem Cells
- Cancer Cell Metabolism
- Tumour heterogeneity
- Carcinogenesis
- Promotion and Progression
- Mutagenesis, Carcinogen Metabolism
- Viral Oncogenesis
- DNA Damage and Repair
- Signalling Pathways
- Gene Expression, Transcriptional Regulation
- Receptors and Signal Transduction
- Computational models of biological systems
- Systems biology
- Omics technologies
- Experimental / Molecular Therapeutics, Pharmacogenomics
- Novel Targets, Delivery Systems
- Drug Discovery / Drug Design
- Drug Resistance
- Mechanisms of Drug Action, Drug Profiling
- New Therapies
- Novel Approaches to Diagnosis of Cancer
- Personalized medicine
- Companion diagnostics
- Translational Research
- Molecular pathology
- Organ Site-Specific Investigations: Preclinical, Diagnosis, Treatment
- Prognostic biomarkers of therapy response
- Biomarkers with clinical relevance, imaging
- Clinical Phase I/II trials with targeted drugs and novel agents
- Prognostic value of oncogenomics
- Animal models of cancer
- Bioinformatics in therapies and clinical trials
- Infrastructures (biobanks, databases, genomic resources, others)
- Radiobiology / Radiation Oncology
- Radiation-activated Signalling Pathways
- Tumour Cell Sensitization to Radiotherapy
- Radiation Oncology; Preclinical and Clinical
- Cell Cycle and Apoptosis in Radiation Responses
- Translational radiation research
- Tumour Immunology
- Immune Suppression and Escape
- Tumour Immunology
- Immunotherapy and Cancer Vaccines
- Tumour antigens and immune effectors
- Prevention and Early Detection
- Clinical Prevention Studies
- Preclinical Prevention Studies, Markers and Prevention
- Vaccination Against Cancer
- Molecular and Genetic Epidemiology
- Biomarkers
- Risk Factors
- Susceptibility Genes
- Risk Assessment
- Genetic Polymorphisms and Cancer Susceptibility
- Genotype / Phenotype Correlations
- Epidemiology
28th Congress of the European Association for Cancer Research (EACR 2024) will be held in Rotterdam, Netherlands on 10-13 Jun 2024.
